Relationship between HALP score and 28-day mortality in very elderly geriatric critically ill patients with acute ischemic stroke

Abstract

Aim: In this study, we aimed to evaluate the relationship between the HALP score, calculated by hemoglobin, albumin, lymphocyte and platelet values, and 28-day mortality in very elderly geriatric critically ill patients with acute ischemic stroke.Material and Method: The study was designed retrospectively and patients aged 85 years and older admitted to the general intensive care unit with the diagnosis of acute ischemic stroke were evaluated. Demographic data, laboratory data and HALP scores of these patients were recorded. Patients who died within 28 days in intensive care follow-up were defined as the Non-Survival group, and patients who did not die were defined as the survival group.Results:There was a statistically significant difference between the groups in terms of hemoglobin values admitted to the intensive care unit (p:0.00). For albumin, patients in the Non-Survival group had lower values, but there was no statistically significant difference between the groups (p: 0.054). Non-Survival group had lower values for lymphocytes and there was a statistically significant difference between the groups (p: 0.00). For platelet value, patients in the Non-Survival group had higher values and there was no statistically significant difference between the groups (p: 0.164). Patients in the Non-Survival group had lower values for HALP score and there was a statistically significant difference between the groups (p: 0.00)Conclusion: The HALP score is associated with 28-day mortality in very elderly geriatric critically ill patients with acute ischemic stroke. However, it has low sensitivity (30.1%) and specificity (27.9%).